Deutsch
Deutschland
Anmelden
Tipp von eurobuch.com
Ähnliche Bücher
Weitere, andere Bücher, die diesem Buch sehr ähnlich sein könnten:
Buch verkaufen
Anbieter, die das Buch mit der ISBN 1617374369 ankaufen:
Suchtools
Buchtipps
Aktuelles
FILTER
- 0 Ergebnisse
Kleinster Preis: 261,99 €, größter Preis: 292,99 €, Mittelwert: 271,77 €
Biomarkers in Breast Cancer - Herausgegeben von Gasparini, Giampietro Hayes, Daniel F.
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)
Herausgegeben von Gasparini, Giampietro Hayes, Daniel F.:
Biomarkers in Breast Cancer - Taschenbuch

2010, ISBN: 9781617374364

[ED: Softcover], [PU: Springer, Berlin], Expert laboratory and clinical researchers from around the world review how to design and evaluate studies of tumor markers and examine their use in breast cancer patients. The authors cover both the major advances in sophisticated molecular methods and the state-of-the-art in conventional prognostic and predictive indicators. Among the topics discussed are the relevance of rigorous study design and guidelines for the validation studies of new biomarkers, gene expression profiling by tissue microarrays, adjuvant systemic therapy, and the use of estrogen, progesterone, and epidermal growth factor receptors as both prognostic and predictive indicators. Highlights include the evaluation of HER2 and EGFR family members, of p53, and of UPA/PAI-1 the detection of rare cells in blood and marrow and the detection and analysis of soluble, circulating markers. It is now well recognized that individualized cancer treatment planning, based on tumor characteristics specific to an individual's cancer, makes it easier to select those most likely to benefit from toxic cancer therapies and to avoid treating those least likely to benefit. In Biomarkers in Breast Cancer: Molecular Diagnostics for Predicting and Monitoring Therapeutic Effect, expert laboratory and clinical researchers from around the world review how to design and evaluate studies of tumor markers, as well as examine their use in breast cancer patients. The authors cover both the major advances in sophisticated molecular methods and the state-of-the-art in conventional prognostic and predictive indicators. Among the topics discussed are the relevance of rigorous study design and guidelines to the validation of new biomarkers, gene expression profiling by tissue microarrays, adjuvant systemic therapy, and the use of estrogen, progesterone, and epidermal growth factor receptors as both prognostic and predictive indicators. Highlights include the evaluation of HER2 and EGFR family members, of p53, and of UPA/PAI-1 the detection of rare cells in blood and marrow and the detection and analysis of soluble, circulating markers. Authoritative and cutting-edge, Biomarkers in Breast Cancer: Molecular Diagnostics for Predicting and Monitoring Therapeutic Effect offers laboratory investigators developing new tumor markers, clinical investigators testing them, and clinicians using them an up-to-date understanding of both the prognostic/predictive indicators and the novel molecular-targeted therapies suitable for individualizing breast cancer therapy. 2010. XII, 342 S. 22 SW-Abb. 229 mm Versandfertig in 2-4 Wochen, DE, [SC: 0.00], Neuware, gewerbliches Angebot, offene Rechnung (Vorkasse vorbehalten)

Neues Buch Booklooker.de
buecher.de GmbH & Co. KG
Versandkosten:Versandkostenfrei, Versand nach Deutschland (EUR 0.00)
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
Biomarkers in Breast Cancer - Herausgegeben von Gasparini, Giampietro Hayes, Daniel F.
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)
Herausgegeben von Gasparini, Giampietro Hayes, Daniel F.:
Biomarkers in Breast Cancer - Taschenbuch

2010, ISBN: 9781617374364

[ED: Softcover], [PU: Springer, Berlin], Expert laboratory and clinical researchers from around the world review how to design and evaluate studies of tumor markers and examine their use in breast cancer patients. The authors cover both the major advances in sophisticated molecular methods and the state-of-the-art in conventional prognostic and predictive indicators. Among the topics discussed are the relevance of rigorous study design and guidelines for the validation studies of new biomarkers, gene expression profiling by tissue microarrays, adjuvant systemic therapy, and the use of estrogen, progesterone, and epidermal growth factor receptors as both prognostic and predictive indicators. Highlights include the evaluation of HER2 and EGFR family members, of p53, and of UPA/PAI-1 the detection of rare cells in blood and marrow and the detection and analysis of soluble, circulating markers. It is now well recognized that individualized cancer treatment planning, based on tumor characteristics specific to an individual's cancer, makes it easier to select those most likely to benefit from toxic cancer therapies and to avoid treating those least likely to benefit. In Biomarkers in Breast Cancer: Molecular Diagnostics for Predicting and Monitoring Therapeutic Effect, expert laboratory and clinical researchers from around the world review how to design and evaluate studies of tumor markers, as well as examine their use in breast cancer patients. The authors cover both the major advances in sophisticated molecular methods and the state-of-the-art in conventional prognostic and predictive indicators. Among the topics discussed are the relevance of rigorous study design and guidelines to the validation of new biomarkers, gene expression profiling by tissue microarrays, adjuvant systemic therapy, and the use of estrogen, progesterone, and epidermal growth factor receptors as both prognostic and predictive indicators. Highlights include the evaluation of HER2 and EGFR family members, of p53, and of UPA/PAI-1 the detection of rare cells in blood and marrow and the detection and analysis of soluble, circulating markers. Authoritative and cutting-edge, Biomarkers in Breast Cancer: Molecular Diagnostics for Predicting and Monitoring Therapeutic Effect offers laboratory investigators developing new tumor markers, clinical investigators testing them, and clinicians using them an up-to-date understanding of both the prognostic/predictive indicators and the novel molecular-targeted therapies suitable for individualizing breast cancer therapy. 2010. XII, 342 S. 22 SW-Abb. 229 mm Versandfertig in 2-4 Wochen, DE, Neuware, gewerbliches Angebot, offene Rechnung (Vorkasse vorbehalten)

Neues Buch Booklooker.de
buecher.de GmbH & Co. KG
Versandkosten:zzgl. Versandkosten.
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
Biomarkers in Breast Cancer - Herausgegeben von Gasparini, Giampietro Hayes, Daniel F.
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)
Herausgegeben von Gasparini, Giampietro Hayes, Daniel F.:
Biomarkers in Breast Cancer - Taschenbuch

2010, ISBN: 9781617374364

[ED: Softcover], [PU: Springer, Berlin], Expert laboratory and clinical researchers from around the world review how to design and evaluate studies of tumor markers and examine their use in breast cancer patients. The authors cover both the major advances in sophisticated molecular methods and the state-of-the-art in conventional prognostic and predictive indicators. Among the topics discussed are the relevance of rigorous study design and guidelines for the validation studies of new biomarkers, gene expression profiling by tissue microarrays, adjuvant systemic therapy, and the use of estrogen, progesterone, and epidermal growth factor receptors as both prognostic and predictive indicators. Highlights include the evaluation of HER2 and EGFR family members, of p53, and of UPA/PAI-1 the detection of rare cells in blood and marrow and the detection and analysis of soluble, circulating markers. It is now well recognized that individualized cancer treatment planning, based on tumor characteristics specific to an individual's cancer, makes it easier to select those most likely to benefit from toxic cancer therapies and to avoid treating those least likely to benefit. In Biomarkers in Breast Cancer: Molecular Diagnostics for Predicting and Monitoring Therapeutic Effect, expert laboratory and clinical researchers from around the world review how to design and evaluate studies of tumor markers, as well as examine their use in breast cancer patients. The authors cover both the major advances in sophisticated molecular methods and the state-of-the-art in conventional prognostic and predictive indicators. Among the topics discussed are the relevance of rigorous study design and guidelines to the validation of new biomarkers, gene expression profiling by tissue microarrays, adjuvant systemic therapy, and the use of estrogen, progesterone, and epidermal growth factor receptors as both prognostic and predictive indicators. Highlights include the evaluation of HER2 and EGFR family members, of p53, and of UPA/PAI-1 the detection of rare cells in blood and marrow and the detection and analysis of soluble, circulating markers. Authoritative and cutting-edge, Biomarkers in Breast Cancer: Molecular Diagnostics for Predicting and Monitoring Therapeutic Effect offers laboratory investigators developing new tumor markers, clinical investigators testing them, and clinicians using them an up-to-date understanding of both the prognostic/predictive indicators and the novel molecular-targeted therapies suitable for individualizing breast cancer therapy. 2010. XII, 342 S. 22 SW-Abb. 229 mm Versandfertig in über 4 Wochen, [SC: 0.00], Neuware, gewerbliches Angebot

Neues Buch Booklooker.de
buecher.de GmbH & Co. KG
Versandkosten:Versandkostenfrei, Versand nach Deutschland (EUR 0.00)
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
Biomarkers in Breast Cancer - Giampietro Gasparini; Daniel F. Hayes
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)
Giampietro Gasparini; Daniel F. Hayes:
Biomarkers in Breast Cancer - Taschenbuch

ISBN: 9781617374364

ID: 9781617374364

Biomedicine; Cancer Research DNA, classification, gene expression, systemic therapy, translation Books Book (Paperback Initiative), Springer Science+Business Media

Neues Buch Springer.com
Versandkosten: EUR 0.00
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
Biomarkers in Breast Cancer - Giampietro Gasparini; Daniel F. Hayes
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)
Giampietro Gasparini; Daniel F. Hayes:
Biomarkers in Breast Cancer - Taschenbuch

2010, ISBN: 9781617374364

ID: 16168404

1st ed. Softcover of orig. ed. 2006, Softcover, Buch, [PU: Humana Press Inc.]

Neues Buch Lehmanns.de
Versandkosten:Versand in 7-9 Tagen, , Versandkostenfrei innerhalb der BRD (EUR 0.00)
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.

Details zum Buch
Biomarkers in Breast Cancer

Expert laboratory and clinical researchers from around the world review how to design and evaluate studies of tumor markers and examine their use in breast cancer patients. The authors cover both the major advances in sophisticated molecular methods and the state-of-the-art in conventional prognostic and predictive indicators. Among the topics discussed are the relevance of rigorous study design and guidelines for the validation studies of new biomarkers, gene expression profiling by tissue microarrays, adjuvant systemic therapy, and the use of estrogen, progesterone, and epidermal growth factor receptors as both prognostic and predictive indicators. Highlights include the evaluation of HER2 and EGFR family members, of p53, and of UPA/PAI-1; the detection of rare cells in blood and marrow; and the detection and analysis of soluble, circulating markers.

Detailangaben zum Buch - Biomarkers in Breast Cancer


EAN (ISBN-13): 9781617374364
ISBN (ISBN-10): 1617374369
Taschenbuch
Erscheinungsjahr: 2010
Herausgeber: SPRINGER VERLAG GMBH
360 Seiten
Gewicht: 0,513 kg
Sprache: eng/Englisch

Buch in der Datenbank seit 14.09.2011 12:33:58
Buch zuletzt gefunden am 14.10.2017 17:09:19
ISBN/EAN: 1617374369

ISBN - alternative Schreibweisen:
1-61737-436-9, 978-1-61737-436-4


< zum Archiv...
Benachbarte Bücher